logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Julia von Tresckow

University of Duisburg-Essen
H指数:20
被引数:2,783

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Time-limited venetoclax combinations in untreated chronic lymphocytic leukemia: Five-year results and patient-reported outcome analysis of the randomized phase 3 CLL13/GAIA trial

限时Venetoclax联合疗法在初治慢性淋巴细胞白血病中的应用：CLL13/GAIA随机III期试验的五年结果及患者报告结局分析

Blood
IF23.1
2026-04-010
PRE
Moritz Fürstenau; Carsten U. Niemann; Sandra Robrecht; Emelie C. Rotbain; Laura Eurelings; Adam Giza; Julia von Tresckow; Can Zhang; Michael Gregor; Patrick Thornton; Philipp B. Staber; Tamar Tadmor; Vesa Lindström; Gunnar Juliusson; Ann Janssens; Caspar da Cunha-Bang; Christof Schneider; Yair Herishanu; Derville O’Shea; Michael Baumann
Acalabrutinib treatment for older (≥80 years old) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial

Acalabrutinib治疗≥80岁及/或虚弱慢性淋巴细胞白血病患者：CLL-Frail试验主要终点分析

Blood
IF23.1
2025-09-080
OAAI
Florian Simon; Rudy Ligtvoet; Jan-Paul Bohn; Thomas Nösslinger; Julia von Tresckow; Rüdiger Liersch; Tobias Gaska; Kathleen Jentsch-Ullrich; Michael Gärtner; Thomas Wolff; Ingo Schwaner; Dominik Wolf; Christof Schneider; Ursula Vehling-Kaiser; Matthias Ritgen; Christian Spoer; Michael Eckart; Thomas Decker; Geothy Chakupurukal; Björn Schöttker; Jens Kisro; Karl-Anton Kreuzer; Eugen Tausch; Stephan Stilgenbauer; Sandra Robrecht; Janina Stumpf; Anna-Maria Fink; Moritz Fürstenau; Kirsten Fischer; Valentin Goede; Michael Hallek; Barbara Eichhorst
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL

维奈克拉-obinutuzumab在CLL中，体能和剂量强度对临床结局的影响

Blood
IF23.1
2025-08-290
OAAI
Othman Al-Sawaf; Moritz Fürstenau; Adam Giza; Sandra Robrecht; Julia von Tresckow; Anna-Maria Fink; Florian Simon; Eugen Tausch; Christof Schneider; Liliya Sivcheva; Anthony Schwarer; Javier Loscertales; Robert Weinkove; Dirk Strumberg; Allanah Kilfoyle; Gunnar Juliusson; Caspar da Cunha-Bang; Thomas Illmer; Michael Gregor; Patrick Thornton
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL

维奈克拉-奥比妥珠单抗在CLL中，体能和剂量强度对临床结局的影响

Blood
IF23.1
2025-08-290
OAAI
Othman Al-Sawaf; Moritz Fürstenau; Adam Giza; Sandra Robrecht; Julia von Tresckow; Anna-Maria Fink; Florian Simon; Eugen Tausch; Christof Schneider; Liliya Sivcheva; Anthony Schwarer; Javier Loscertales; Robert Weinkove; Dirk Strumberg; Allanah Kilfoyle; Gunnar Juliusson; Caspar da Cunha-Bang; Thomas Illmer; Michael Gregor; Patrick Thornton
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-05-170
OAAI
Langerbeins, Petra; Giza, Adam; Robrecht, Sandra; Cramer, Paula; von Tresckow, Julia; Al-Sawaf, Othman; Fink, Anna Maria; Fuerstenau, Moritz; Kater, Arnon; van der Spek, Ellen; Niemann, Carsten Utoft; da Cunha-Bang, Caspar; Tausch, Eugen; Schneider, Christof; Stilgenbauer, Stephan; Fischer, Kirsten; Hallek, Michael; Eichhorst, Barbara
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-04-050
OAAI
Cramer, Paula; von Tresckow, Julia; Fink, Anna-Maria; Robrecht, Sandra; Giza, Adam; Tausch, Eugen; Mueller, Lothar; Knauf, Wolfgang; Zingerle, Matthias; Al-Sawaf, Othman; Langerbeins, Petra; Fischer, Kirsten; Kreuzer, Karl-Anton; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial
NATURE MEDICINE
IF50
2023-12-0914
OAAI
Al-Sawaf, Othman; Ligtvoet, Rudy; Robrecht, Sandra; Stumpf, Janina; Fink, Anna-Maria; Tausch, Eugen; Schneider, Christof; Boettcher, Sebastian; Mikusko, Martin; Ritgen, Matthias; Schetelig, Johannes; von Tresckow, Julia; Vehling-Kaiser, Ursula; Gaska, Tobias; Wendtner, Clemens Martin; Chapuy, Bjoern; Fischer, Kirsten; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Staber, Philipp; Niemann, Carsten; Hallek, Michael; Eichhorst, Barbara
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

CLL历史上的其他恶性肿瘤: ERIC进行的一项国际多中心研究，欧洲CLL研究倡议，和谐

ECLINICALMEDICINE
IF10
2023-11-016
OAAI
Chatzikonstantinou, Thomas; Scarfo, Lydia; Karakatsoulis, Georgios; Minga, Eva; Chamou, Dimitra; Iacoboni, Gloria; Kotaskova, Jana; Demosthenous, Christos; Smolej, Lukas; Mulligan, Stephen; Alcoceba, Miguel; Al-Shemari, Salem; Aurran-Schleinitz, Therese; Bacchiarri, Francesca; Bellido, Mar; Bijou, Fontanet; Calleja, Anne; Medina, Angeles; Khan, Mehreen Ali; Cassin, Ramona; Chatzileontiadou, Sofia; Collado, Rosa; Christian, Amy; Davis, Zadie; Dimou, Maria; Donaldson, David; Dos Santos, Gimena; Dreta, Barbara; Efstathopoulou, Maria; El-Ashwah, Shaimaa; Enrico, Alicia; Fresa, Alberto; Galimberti, Sara; Galitzia, Andrea; Garcia-Serra, Rocio; Gimeno, Eva; Gonzalez-Gascon-Y-Marin, Isabel; Gozzetti, Alessandro; Guarente, Valerio; Guieze, Romain; Gogia, Ajay; Gupta, Ritu; Harrop, Sean; Hatzimichael, Eleftheria; Herishanu, Yair; Hernandez-Rivas, Jose-Angel; Inchiappa, Luca; Jaksic, Ozren; Janssen, Susanne; Kalicinska, Elzbieta; Kamel, Laribi; Karakus, Volkan; Kater, Arnon P.; Kho, Bonnie; Kislova, Maria; Konstantinou, Eliana; Koren-Michowitz, Maya; Kotsianidis, Ioannis; Kreitman, Robert J.; Labrador, Jorge; Lad, Deepesh; Levin, Mark-David; Levy, Ilana; Longval, Thomas; Lopez-Garcia, Alberto; Marquet, Juan; Martin-Rodriguez, Lucia; Maynadie, Marc; Maslejova, Stanislava; Mayor-Bastida, Carlota; Mihaljevic, Biljana; Milosevic, Ivana; Miras, Fatima; Moia, Riccardo; Morawska, Marta; Murru, Roberta; Nath, Uttam Kumar; Navarro-Bailon, Almudena; Oliveira, Ana C.; Olivieri, Jacopo; Oscier, David; Panovska-Stavridis, Irina; Papaioannou, Maria; Papajik, Tomas; Kubova, Zuzana; Phumphukhieo, Punyarat; Pierie, Cheyenne; Puiggros, Anna; Rani, Lata; Reda, Gianluigi; Rigolin, Gian Matteo; Ruchlemer, Rosa; de Deus Santos, Marcos Daniel; Schipani, Mattia; Schiwitza, Annett; Shen, Yandong; Simkovic, Martin; Smirnova, Svetlana; Soliman, Dina Sameh Abdelrahman; Spacek, Martin; Tadmor, Tamar; Tomic, Kristina; Tse, Eric; Vassilakopoulos, Theodoros; Visentin, Andrea; Vitale, Candida; von Tresckow, Julia; Vrachiolias, George; Vukovic, Vojin; Walewska, Renata; Wasik-Szczepanek, Ewa; Xu, Zhenshu; Yagci, Munci; Yanez, Lucrecia; Yassin, Mohamed; Zuchnicka, Jana; Angelopoulou, Maria; Antic, Darko; Biderman, Bella; Catherwood, Mark; Claus, Rainer; Coscia, Marta; Cuneo, Antonio; Demirkan, Fatih; Espinet, Blanca; Gaidano, Gianluca; Kalashnikova, Olga B.; Laurenti, Luca; Nikitin, Eugene; Pangalis, Gerassimos A.; Panagiotidis, Panagiotis; Popov, Viola Maria; Pospisilova, Sarka; Sportoletti, Paolo; Stavroyianni, Niki; Tam, Constantine; Trentin, Livio; Chatzidimitriou, Anastasia; Bosch, Francesc; Doubek, Michael; Ghia, Paolo; Stamatopoulos, Kostas
Treatment with idelalisib in patients with chronic lymphocytic leukemia - real world data from the registry of the German CLL Study Group

慢性淋巴细胞白血病患者的idelalisib治疗-来自德国CLL研究组注册表的真实数据

ANNALS OF HEMATOLOGY
IF2.4
2023-06-265
OAAI
von Tresckow, Julia; Heyl, Nikola; Robrecht, Sandra; Giza, Adam; Aldaoud, Ali; Schlag, Rudolf; Klausmann, Martine; Linde, Hartmut; Stein, Wolfgang; Schwarzer, Andreas; Fischer, Kirsten; Cramer, Paula; Eichhorst, Barbara; Hallek, Michael; Fink, Anna Maria
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2023-05-11124
PRE
Eichhorst, Barbara; Niemann, Carsten U.; Kater, Arnon P.; Fuerstenau, Moritz; von Tresckow, Julia; Zhang, Can; Robrecht, Sandra; Gregor, Michael; Juliusson, Gunnar; Thornton, Patrick; Staber, Philipp B.; Tadmor, Tamar; Lindstrom, Vesa; da Cunha-Bang, Caspar; Schneider, Christof; Poulsen, Christian B.; Illmer, Thomas; Schoettker, Bjoern; Noesslinger, Thomas; Janssens, Ann; Christiansen, Ilse; Baumann, Michael; Frederiksen, Henrik; van der Klift, Marjolein; Jaeger, Ulrich; Leys, Maria B. L.; Hoogendoorn, Mels; Lotfi, Kourosh; Hebart, Holger; Gaska, Tobias; Koene, Harry; Enggaard, Lisbeth; Goede, Jereon; Regelink, Josien C.; Widmer, Anouk; Simon, Florian; De Silva, Nisha; Fink, Anna-Maria; Bahlo, Jasmin; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl A.; Ritgen, Matthias; Brueggemann, Monika; Tausch, Eugen; Levin, Mark-David; van Oers, Marinus; Geisler, Christian; Stilgenbauer, Stephan; Hallek, Michael
Long-term follow-up and health-related quality of life among cancer survivors with stage IEA orbital-type lymphoma after external photon-beam radiotherapy: Results from a longitudinal study
HEMATOLOGICAL ONCOLOGY
IF3.9
2022-08-073
OAAI
Hoffmann, Christian; Rating, Philipp; Bechrakis, Nikolaos; Eckstein, Anja; Sokolenko, Ekaterina; Jabbarli, Leyla; Westekemper, Henrike; Mohr, Christopher; Schmeling, Claus; Huettmann, Andreas; von Tresckow, Julia; Goericke, Sophia; Deuschl, Cornelius; Johansson, Patricia; Poettgen, Christoph; Gauler, Thomas; Guberina, Nika; Moliavi, Sourour; Stuschke, Martin; Guberina, Maja
Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial
LEUKEMIA
IF13.4
2022-06-254
OAAI
von Tresckow, Julia; Cramer, Paula; Robrecht, Sandra; Langerbeins, Petra; Fink, Anna-Maria; Al-Sawaf, Othman; Fuerstenau, Moritz; Illmer, Thomas; Klaproth, Holger; Tausch, Eugen; Ritgen, Matthias; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Boettcher, Sebastian; Eichhorst, Barbara F.; Hallek, Michael
COVID-19 among fit patients with CLL treated with venetoclax-based combinations
LEUKEMIA
IF13.4
2020-06-2938
OAAI
Fuerstenau, Moritz; Langerbeins, Petra; De Silva, Nisha; Fink, Anna Maria; Robrecht, Sandra; von Tresckow, Julia; Simon, Florian; Hohloch, Karin; Droogendijk, Jolanda; van der Klift, Marjolein; van der Spek, Ellen; Illmer, Thomas; Schoettker, Bjoern; Fischer, Kirsten; Wendtner, Clemens M.; Tausch, Eugen; Stilgenbauer, Stephan; Niemann, Carsten U.; Gregor, Michael; Kater, Arnon P.; Hallek, Michael; Eichhorst, Barbara
Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
HAEMATOLOGICA
IF7.9
2020-02-2715
OAAI
Cramer, Paula; von Tresckow, Julia; Robrecht, Sandra; Bahlo, Jasmin; Furstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J.; Vehling-Kaiser, Ursula; Durig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy
LEUKEMIA
IF13.4
2019-11-147
PREAI
Fuerstenau, Moritz; Hopfinger, Georg; Robrecht, Sandra; Fink, Anna-Maria; Al-Sawaf, Othman; Langerbeins, Petra; Cramer, Paula; Von Tresckow, Julia; Maurer, Christian; Kutsch, Nadine; Hoechstetter, Manuela; Dreyling, Martin; Lange, Elisabeth; Kneba, Michael; Stilgenbauer, Stephan; Doehner, Hartmut; Hensel, Manfred; Kiehl, Michael G.; Jaeger, Ulrich; Wendtner, Clemens-Martin; Goede, Valentin; Fischer, Kirsten; von Bergwelt-Baildon, Michael; Eichhorst, Barbara; Hallek, Michael; Theurich, Sebastian
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL)
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2019-07-084
OAAI
Al-Sawaf, Othman; Bazeos, Alexandra; Robrecht, Sandra; Bahlo, Jasmin; Gower, Craig; Fink, Anna-Maria; Tresckow, Julia; Cramer, Paula; Langerbeins, Petra; Kutsch, Nadine; Humphrey, Kathryn; Fingerle-Rowson, Guenter; Stilgenbauer, Stephan; Wendtner, Clemens-Martin; Fischer, Kirsten; Eichhorst, Barbara; Hallek, Michael; Goede, Valentin

研究方向

暂未获取到该数据
M
Michael Hallek
H 指数:124论文数:1,647被引数:7.1万
B
Barbara Eichhorst
H 指数:62论文数:438被引数:2.1万
K
Kirsten Fischer
H 指数:48论文数:389被引数:1.5万
S
Sandra Robrecht
H 指数:30论文数:152被引数:3,815
S
Stephan Stilgenbauer
H 指数:126论文数:1,220被引数:7.3万
A
Anna‐Maria Fink
H 指数:28论文数:134被引数:3,921
P
Paula Cramer
H 指数:31论文数:177被引数:6,836
O
Othman Al‐Sawaf
H 指数:34论文数:184被引数:6,443
C
Clemens‐Martin Wendtner
H 指数:65论文数:436被引数:2.6万
M
Moritz Fürstenau
H 指数:18论文数:97被引数:1,270